December 8, 2025 — browser does not support iframeWe write a great deal here about obesity care. That phrase reflects the fact that obesity is a complex chronic disease typically requiring lifelong care. Not just a simple weight loss intervention. But most of the world is not thinking in those terms. And the research symposium last week at NIH […]
September 9, 2025 — The progress we have witnessed in 25 years of working on obesity care has been nothing short of remarkable. Especially in the last four years with the introduction of advanced new obesity medicines. But let’s step back from the minutia of research, clinical care, and policy, to look at the big challenges that remain. When […]
August 27, 2025 — It’s entertaining in a perverse way. Cluelessness about the potential of orforglipron is impossible to miss in the news about Lilly’s new oral GLP-1 medicine for obesity this month. The company announced topline results from the first of two pivotal studies for this medicine on August 7 and investors decided the drug was a dud. […]
August 7, 2025 — At the opening of the ANZMOSS (Australian and New Zealand Metabolic and Obesity Surgery Society) meeting today, we had the unique privilege of helping people peer into the future of obesity care. Endocrine surgeon Juan Pablo Pantoja presented a view of the future of bariatric surgery in the era of a medical frenzy. The frenzy, […]
June 11, 2025 — Honestly, we cannot figure out why this basic fact of obesity treatment seems so hard for so many people to grasp. New, advanced medicines for obesity don’t work well when a person doesn’t take them. A new study in Obesity drives this point home. Hamlet Gasoyan and colleagues found that discontinuations and sub-optimal dosing of […]
